Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy [Phase 2, Phase 3]
A clinical trial update for TIGER-1 evaluating rociletinib (CO-1686) vs erlotinib in EGFR-mutant metastatic non-small cell lung cancer; the …
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing docetaxel to an intercalated erlotinib-docetaxel regimen in relapsed EGFR wild-type, ALK-negative non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial [Phase 2]
Phase 2 trial evaluating maintenance low-dose oral Navelbine in non-small cell lung cancer patients (Stage IIIB and IV) has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors [Phase 2]
Phase 2 trial evaluating atezolizumab with bevacizumab, carboplatin, and pemetrexed for EGFR-mutant metastatic non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer [Phase 3]
A Phase 3 global trial evaluating durvalumab alone or with tremelimumab versus standard of care in locally advanced or metastatic non-small …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer [Phase 3]
Phase 3 study evaluating Chinese Medicine plus chemotherapy maintenance in advanced cancer; trial completed.
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation [Phase 2]
Phase 2 clinical trial update investigating cabozantinib in non-small cell lung cancer with MET deregulation.
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC [Phase 3]
Phase 3 trial evaluating the combination of Apatinib with EGFR-TKI in advanced EGFR-TKI resistant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating anti-PD1 antibody-activated tumor-infiltrating lymphocytes in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial of atezolizumab with carboplatin and nab-paclitaxel vs carboplatin and nab-paclitaxel in stage IV non-squamous non-small cell …
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating intrapleural bevacizumab for malignant pleural effusion in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Pemetrexed/Cisplatin Intercalating Gefitinib Treating EGFR Wild NSCLC [Phase 2]
Phase 2 trial evaluating pemetrexed/cisplatin intercalating gefitinib for EGFR wild-type non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate [Phase 2]
Phase 2 clinical trial investigating inhaled beclomethasone propionate to prevent radiotherapy-induced pneumonia in locally advanced non-sma…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating BLP25 Liposome Vaccine with Bevacizumab after chemo and radiation in newly diagnosed stage IIIA/IIIB non-s…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating carboplatin, bevacizumab, and pemetrexed in advanced non-small cell lung cancer has completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating an Epitope Peptide for safety and efficacy in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients [Phase 2]
Phase 2 trial evaluating sintilimab in combination with metformin as first-line therapy for advanced non-small cell lung cancer refractory t…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating an epitope peptide for advanced non-small cell lung cancer has completed safety and efficacy assessments.
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042) [Phase 3]
Phase 3 trial comparing pembrolizumab to platinum-based chemotherapy in PD-L1-positive advanced/metastatic non-small cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47 [Phase 1, Phase 2]
Phase I/II open-label study of immunoconjugate L-DOS47 in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer [Phase 2]
Phase 2 clinical trial investigating intrapleural docetaxel administration via medical pleuroscopy for malignant pleural effusion in non-sma…
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer [Phase 4]
Phase 4 trial comparing cisplatin/vinblastine followed by radiotherapy versus paclitaxel/carboplatin in locally advanced non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating carboplatin and paclitaxel with/without bevacizumab and/or cetuximab in stage IV or recurrent non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating paclitaxel and carboplatin with bexarotene in advanced non-small-cell lung carcinoma was terminated; results post…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib with or without fulvestrant in stage IIIB or IV non-small cell lung cancer has completed.